XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Beginning of period (in shares) at Oct. 02, 2021   28,047,000        
Exercise of stock options and vesting of other share-based awards   228,000        
Treasury shares purchased (in shares)   (416,000)        
End of period (in shares) at Apr. 02, 2022   27,859,000        
Beginning of period at Oct. 02, 2021 $ 1,028,232 $ 538 $ 639,778 $ (1,043,091) $ 1,433,991 $ (2,984)
Exercise of stock options and vesting of other share-based awards   3        
Share-based compensation expense     12,178      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (10,781)      
Treasury shares purchased       (35,135)    
Net income 50,292       50,292  
Other comprehensive income (loss) (4,198)         (4,198)
End of period at Apr. 02, 2022 1,040,591 $ 541 641,175 (1,078,226) 1,484,283 (7,182)
Beginning of period (in shares) at Jan. 01, 2022   27,997,000        
Exercise of stock options and vesting of other share-based awards   168,000        
Treasury shares purchased (in shares)   (306,000)        
End of period (in shares) at Apr. 02, 2022   27,859,000        
Beginning of period at Jan. 01, 2022 1,044,095 $ 539 642,654 (1,053,222) 1,457,414 (3,290)
Exercise of stock options and vesting of other share-based awards   2        
Share-based compensation expense     5,908      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (7,387)      
Treasury shares purchased       (25,004)    
Net income 26,869       26,869  
Other comprehensive income (loss) (3,892)         (3,892)
End of period at Apr. 02, 2022 $ 1,040,591 $ 541 641,175 (1,078,226) 1,484,283 (7,182)
Beginning of period (in shares) at Oct. 01, 2022 27,679,000 27,679,000        
Exercise of stock options and vesting of other share-based awards   209,000        
Treasury shares purchased (in shares)   (241,000)        
End of period (in shares) at Apr. 01, 2023 27,647,000 27,647,000        
Beginning of period at Oct. 01, 2022 $ 1,095,731 $ 541 652,467 (1,093,483) 1,572,234 (36,028)
Exercise of stock options and vesting of other share-based awards   2        
Share-based compensation expense     11,482      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (12,282)      
Treasury shares purchased       (23,877)    
Net income 83,034       83,034  
Other comprehensive income (loss) 28,292         28,292
End of period at Apr. 01, 2023 $ 1,182,382 $ 543 651,667 (1,117,360) 1,655,268 (7,736)
Beginning of period (in shares) at Dec. 31, 2022   27,612,000        
Exercise of stock options and vesting of other share-based awards   160,000        
Treasury shares purchased (in shares)   (125,000)        
End of period (in shares) at Apr. 01, 2023 27,647,000 27,647,000        
Beginning of period at Dec. 31, 2022 $ 1,150,259 $ 541 654,059 (1,104,953) 1,614,424 (13,812)
Exercise of stock options and vesting of other share-based awards   2        
Share-based compensation expense     5,799      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (8,191)      
Treasury shares purchased       (12,407)    
Net income 40,844       40,844  
Other comprehensive income (loss) 6,076         6,076
End of period at Apr. 01, 2023 $ 1,182,382 $ 543 $ 651,667 $ (1,117,360) $ 1,655,268 $ (7,736)